From Our License Partners:
Taylor, D.D., Gerçel-Taylor. C., Lyons, K.S., Stanson, J., and Whiteside, T.L. Suppression of TcR/CD3-zeta by shed membrane vesicles from ovarian tumors. Clinical Cancer Research 9:5113-5119, 2003.
Taylor, D.D., Gercel-Taylor, C. Tumor-derived exosomes as mediators of T-cell signaling defects. British Journal of Cancer 92:305-311, 2005
Taylor, D.D., Akyol, S., Gerçel-Taylor, C. Pregnancy-associated exosomes and their modulation of T-cell signaling. Journal of Immunology 176: 1534-1542, 2006.
Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. “Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.” Nat Cell Biol. 2008 May;10(5):619-24. http://www.nature.com/ncb/journal/v10/n5/abs/ncb1725.html
Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. “Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR.” Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3794-9. PMCID2656159
Rak J, Al-Nedawi K, Meehan B, Guha A. “Tumor cell-derived microvesicles.” PCT/International Publication Number WO 2009/021322 A1.
Al-Nedawi K, Meehan B, Rak J. “Microvesicles: messengers and mediators of tumor progression.” Cell Cycle. 2009 Jul 1; vol. 8(13) pp. 2014-8.
Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD. Trophoblast derived exosomes mediate monocyte recruitment and differentiation. American Journal of Reproductive Immunology, 65:65-77, 2011.